Skip to content
OpenCapital
Get started

Perspective Therapeutics CATX Free cash flow margin

Free cash flow margin at other companies

Eli Lilly logo
Eli LillyLLY
16.4%+8.7pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-225.6%-334pp
Immunome logo
ImmunomeIMNM
-5,118.9%-8,601pp
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-428.4%-214pp
Lantheus Holdings logo
Lantheus HoldingsLNTH
24.4%-6.4pp
uniQure logo
uniQureQURE
-953.7%+169pp

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0×0.0×
Current ratio8.7×-8.3×